<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="144660">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01967485</url>
  </required_header>
  <id_info>
    <org_study_id>2013-P-002161</org_study_id>
    <nct_id>NCT01967485</nct_id>
  </id_info>
  <brief_title>Text Messaging Adherence to Stimulant Medication</brief_title>
  <official_title>Text Messaging Adherence to Stimulant Medication</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Massachusetts General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>American Academy of Child Adolescent Psychiatry.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Massachusetts General Hospital</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if an individualized text messaging intervention
      for the parents of children with Attention Deficit/Hyperactivity Disorder is effective in
      improving medication adherence and disease management.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2014</start_date>
  <completion_date type="Anticipated">December 2015</completion_date>
  <primary_completion_date type="Anticipated">June 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research</study_design>
  <primary_outcome>
    <measure>Medication Adherence</measure>
    <time_frame>Six Months</time_frame>
    <safety_issue>No</safety_issue>
    <description>This study will use an electronic system to notify investigators each time the pill bottle is opened to determine if medication was taken as scheduled.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Attention Deficit Hyperactivity Disorder</condition>
  <arm_group>
    <arm_group_label>Text Messaging</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Text messaging to the parents of children. Children will receive open treatment for Attention Deficit/Hyperactivity Disorder (ADHD) with stimulant medication.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No Text Messaging</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Children will receive open treatment for ADHD with stimulant medication. This group will not get the text messaging intervention, but will receive treatment as usual.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Text- Messaging</intervention_name>
    <description>Text messages will be sent to the parents of children enrolled in the study.</description>
    <arm_group_label>Text Messaging</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Treatment as usual</intervention_name>
    <description>Children will receive stimulant treatment for ADHD.</description>
    <arm_group_label>Text Messaging</arm_group_label>
    <arm_group_label>No Text Messaging</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male or female children ages 6-12 years

          -  A diagnosis of ADHD (inattentive, hyperactive/impulsive, or combined type) according
             to the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV)
             based on clinical assessment and supported by a Clinical Global Impression- ADHD
             (CGI-ADHD) Severity Score of at least 4 (Moderately Ill)

          -  Has a parent in possession of a cellular phone with text messaging capabilities and
             is interested in and willing to receive planned text messages

        Exclusion Criteria:

          -  Any serious, unstable, chronic medical condition, per clinician assessment

          -  Cardiovascular disease

          -  Current or past history of seizures

          -  Prior treatment with stimulant medication

          -  Pregnant or nursing females

          -  Investigator and his/her immediate family; defined as the investigator's spouse,
             parent, child, grandparent, or grandchild

          -  Unstable psychiatric illness other than ADHD, including, but not limited to: Autism,
             Bipolar Disorder, Psychosis, Major Depressive Disorder, Anorexia, Bulimia,
             Post-Traumatic Stress Disorder and Anxiety Disorders

          -  History of multiple adverse drug reactions

          -  Presence of suicidal risk, or homicidality

          -  Concomitant medication with primarily central nervous system activity

          -  Unwilling/unable to comply with study procedures

          -  Poor command of the English language
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>12 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mai Uchida, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Massachusetts General Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Brittany Hughes, BA</last_name>
    <phone>617-643-4875</phone>
    <email>bchughes@partners.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Rebecca Grossman, BA</last_name>
    <phone>617-643-1432</phone>
    <email>Rgossman1@partners.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brittany Hughes, BA</last_name>
      <phone>617-643-4875</phone>
      <email>bchughes@mgh.harvard.edu</email>
    </contact>
    <contact_backup>
      <last_name>Rebecca Grossman, BA</last_name>
      <phone>617-643-1432</phone>
      <email>rgrossman1@mgh.harvard.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Mai Uchida, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Joseph Biederman, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <lastchanged_date>February 26, 2014</lastchanged_date>
  <firstreceived_date>October 18, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Massachusetts General Hospital</investigator_affiliation>
    <investigator_full_name>Mai Uchida</investigator_full_name>
    <investigator_title>Child Psychiatrist, Pediatric Psychopharmacology and Adult ADHD Program, Massachusetts General Hospital; Instructor in Psychiatry, Harvard Medical School</investigator_title>
  </responsible_party>
  <keyword>Attention Deficit Hyperactivity Disorder</keyword>
  <keyword>Medication adherence</keyword>
  <keyword>Disease management</keyword>
  <keyword>Text message</keyword>
  <keyword>ADHD</keyword>
  <keyword>Children</keyword>
  <keyword>Reminder systems</keyword>
  <keyword>Text Messaging</keyword>
  <keyword>Telemedicine</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>No</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Attention Deficit Disorder with Hyperactivity</mesh_term>
    <mesh_term>Hyperkinesis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Central Nervous System Stimulants</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
